Seroprevalencia de toxoplasmosis y factores asociados en mujeres del municipio de Vinto, Cochabamba, Bolivia, 2023

Moria Villca-Chuquichambi; Abigail Condori Mamani; Raquel Orellana Guevara

doi:10.53732/rccsalud/2025.e7127

Authors

Moria Villca-Chuquichambi Universidad Adventista de Bolivia. Cochabamba, Bolivia https://orcid.org/0000-0002-9159-9711
Abigail Condori Mamani Universidad Adventista de Bolivia. Cochabamba, Bolivia https://orcid.org/0000-0002-1918-7958
Raquel Orellana Guevara Universidad Adventista de Bolivia. Cochabamba, Bolivia https://orcid.org/0000-0002-4835-5789

DOI:

https://doi.org/10.53732/rccsalud/2025.e7127

Keywords:

associated factors, seroprevalence, toxoplasmosis

Abstract

Introduction. Toxoplasmosis is a parasitic disease caused by Toxoplasma gondii, which can have adverse effects on women's health, especially during pregnancy. In Bolivia, the prevalence of this infection varies by region and sociodemographic factors. Objective. To determine the seroprevalence of Toxoplasma gondii in women from the municipality of Vinto, Cochabamba, Bolivia, and to analyze the factors associated with its infection. Materials and Method. A quantitative, descriptive, and cross-sectional study was conducted with 156 women. Serum samples were analyzed using the Indirect Hemagglutination Test (HAI TOXO POLYCHACO) to detect IgG antibodies against Toxoplasma gondii. Pearson’s chi-square test was applied to assess the relationship between the seroprevalence of toxoplasmosis and the age ranges of the women, as well as cat ownership. Results. Of the 156 women, 42.3% (66 women) tested positive for IgG antibodies against T. gondii. The highest prevalence was observed in the 18-30 age range, although no statistically significant association was found between seropositivity and age range (p = 0.340). Similarly, no significant relationship was found between cat ownership and seropositivity (p = 0.241). Conclusion. The findings emphasize the importance of conducting further studies to identify other factors associated with the transmission and frequency of toxoplasmosis in this population.

References

Vera LL, Pérez Portillo V, Núñez Lezcano F, San Miguel MC. Prevalencia de toxoplasmosis en Paraguay enfocada a grupos de riesgo. Med. clín. soc. 2024;8(3):382-9. https://doi.org/10.52379/mcs.v8i3.442

Vilela V í cius, Khan MJ, Mubaraki M, Jahan S, Khattak B, Khan M, et al. b. Trop. Med. Infect. Dis. 2022;7(12):430. https://doi.org/10.3390/tropicalmed7120430

Mao F, Yang Y peng, Chen Y, Zhang Q, Ding X, Ni B, et al. Seroprevalence and Risk Factors of Toxoplasma gondii Infection Among High-Risk Populations in Jiangsu Province, Eastern China. Front. Cell. Infect. Microbiol. 2021;11. https://doi.org/10.3389/fcimb.2021.783654

Ocampo Fernández L, González Vatteone C, Arévalo de Guillen Y, Aria Zaya L, Rojas Segovia A, Bernal Vera C, et al. Prevalencia de baja avidez de Inmunoglobulina G anti Toxoplasma gondii y comportamiento de riesgo para toxoplasmosis en embarazada. Rev. Nac. (Itauguá). 2023;15(2):14-28. https://doi.org/10.18004/rdn2023.dic.02.014.028

Baque Mero AP, Sancan Soledispa BP, Véliz Castro TI. Prevalencia de toxoplasmosis, factores de riesgo y su asociación a complicaciones en la gestación en Latinoamérica. Pentaciencias. 2023;5(3):134-48. https://doi.org/10.59169/pentaciencias.v5i3.526

Krings A, Jacob J, Seeber F, Pleyer U, Walker J, Stark K, et al. Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011–2016. Emerg Infect Dis. 2021;27(8):2097-106. https://doi.org/10.3201/eid2708.203740

Nkutxi Vueba A, Perez Faria C, Almendra R, Santana P, do Céu Sousa M. Serological prevalence of toxoplasmosis in pregnant women in Luanda (Angola): Geospatial distribution and its association with socio-demographic and clinical-obstetric determinants. PLOS ONE. 2020;15(11):e0241908. https://doi.org/10.1371/journal.pone.0241908

Morais R dos AB, Carmo EL do, Costa WS, Marinho R, Póvoa M. T. gondii Infection in Urban and Rural Areas in the Amazon: Where Is the Risk for Toxoplasmosis? Int. J. Environ. Res. Public Health. 2021;18(16):8664. https://doi.org/10.3390/ijerph18168664

Damar Çakırca T, Can İN, Deniz M, Torun A, Akçabay Ç, Güzelçiçek A. Toxoplasmosis: A Timeless Challenge for Pregnancy. Trop. Med. Infect. Dis. 2023;8(1):63. https://doi.org/10.3390/tropicalmed8010063

Anagua C, Cuellar J, Toro A, Paniagua L. Detección de anticuerpos anti-toxoplasma Gondii por HAI en estudiantes universitarios en la carrera de bioquímica y farmacia, facultad de cs. De la salud de la universidad cristiana de Bolivia desde septiembre a diciembre del 2019 en santa cruz – Bolivia. UCS. 2022;23(1):28-31. https://doi.org/10.61070/ucs.v23i1.9

Quispe Cabana YZ, Soto Sánchez ML. Frecuencia de toxoplasmosis y su relación con el diagnóstico clínico de pacientes que asistieron al Instituto SELADIS entre enero 2021 y julio 2022. REV CC. 2023;11(2):65-79. http://conciencia.farbio.edu.bo/index.php/ojs/article/view/190

Barrientos CE. Estudio de factores de riesgo para toxoplasmosis y seroprevalencia en estudiantes de la carrera de Bioquímica U.S.F.X.CH. BS. 2019;2(4):40-50. https://revistas.usfx.bo/index.php/bs/article/view/314

Zavala-Hoppe AN, Piguave-Cacao RR, Ponce-Macias NN. Epidemiología y Factores de riesgo de la Toxoplasmosis en los países de Latinoamérica. MQRInvestigar. 2025;9(1):e234-e234. https://doi.org/10.56048/MQR20225.9.1.2025.e234

Sánchez Artigas R, Araujo Baptista L, Brossard Peña E, Atair Falconi F, Ramos Campi Y, Barba Maggi MA. Prevalencia de toxoplasmosis en estudiantes de la Universidad Nacional de Chimborazo en Ecuador. Rev Cubana Inves Bioméd. 2018;37(2):117-26. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002018000200013

Mihu AG, Balta C, Marti DT, Paduraru AA, Lupu MA, Olariu TR. Seroprevalence of Toxoplasma gondii infection among women of childbearing age in an endemic region of Romania, 2016–2018. Parasite. 2020;27:59. https://doi.org/10.1051/parasite/2020057

Radoi CL, Zlatian OM, Bălășoiu M, Giubelan L, Stoian A, Dragonu L, et al. Toxoplasma gondii Seroprevalence and Trends in Women Presenting for Toxoplasma Screening in South-West Romania. Microorganisms. 2023;11(8)2057. https://doi.org/10.3390/microorganisms11082057

Mosawi SH, Zarghona Z, Dalimi A, Jokelainen P, Safa A, Mohammadi M, et al. Particularly neglected in countries with other challenges: High Toxoplasma gondii seroprevalence in pregnant women in Kabul, Afghanistan, while a low proportion know about the parasite. PLoS ONE. 2019;14(10);e0223585. https://doi.org/10.1371/journal.pone.0223585

Passos A, Bollela V, Furtado JM, Lucena MM, Bellissimo-Rodrigues F, Paula JS, et al. Prevalence and risk factors of toxoplasmosis among adults in a small Brazilian city. Rev. Soc. Bras. Med. Trop. 2018;51(06):781-7. https://doi.org/10.1590/0037-8682-0214-2017

Elemo SA. Toxoplasmosis Sero-Prevalence, Awareness and Risk Behavior Among Pregnant Women Following Antenatal Care in Asella Teaching and Referral Hospital, Asella, Ethiopia. Int. J. Biomed. Sci. Eng. 2020;8(3):28-35. https://doi.org/10.11648/j.ijbse.20200803.12

Bahadori A, Babazadeh T, Chollou KM, Moqadam H, Zendeh MB, Valipour B, et al. Seroprevalence and risk factors associated with toxoplasmosis in nomadic, rural, and urban communities of northwestern Iran. Front Public Health. 2025;13:1516693. https://doi.org/10.3389/fpubh.2025.1516693